New Covid-19 variant C.1.2 may be more infectious: Maha task force member

A new variant of coronavirus - C.1.2 - which has been detected in South Africa and some other countries, could be more infectious than earlier strains and may evade vaccines

New Covid-19 variant C.1.2 may be more infectious:  Maha task force member
Press Trust of India Mumbai
2 min read Last Updated : Sep 02 2021 | 11:44 PM IST

A new variant of coronavirus - C.1.2 - which has been detected in South Africa and some other countries, could be more infectious than earlier strains and may evade vaccines, said an infectious diseases consultant who is also a member of the Maharashtra COVID-19 task force on Thursday.

Dr Vasant Nagvekar, an infectious diseases consultant with a Mumbai hospital and a member of the government task force on COVID-19, said the new variant also has mutation rate that is nearly "twice as fast" as the rate of other variants.

It requires more detailed study as we know very little about it, he said. "A new SARS-CoV-2 variant, C.1.2, just identified in South Africa and other countries with concerns that it could be more infectious and evade vaccines. What sets this variant apart is the speed at which it is mutating. This variant is changing and mutating at a rapid rate which are seen in many variants of concern and variants of interest," he said in a statement. SARS-CoV-2 is the virus which causes COVID-19. Masking, vaccination and avoiding major gatherings are precautions that need to be taken, Nagvekar said. If one experienced symptoms associated with coronavirus, then that person should immediately get tested and opt for early treatment based on diagnostic result, he said.

Nagvekar, when asked about the number of different mutations, said there are COVID-19 variants of concern - Alpha, Deta, Gamma and Delta - and variants of interest - Ela, Lita, Kappa, Lamda and Mu. He explained that variants of concern meant they showcased genetic changes that are predicted or known to affect virus characteristics like transmissibility, disease severity, immune escape, diagnostic or therapeutic escape. Asked about details of the new variant, Nagvekar said experts are yet to ascertain what could be the symptoms, but they claim they may be similar to COVID-19 symptoms. Coronavirus symptoms include fever or chills, cough, runny nose, shortness of breath or difficulty in breathing, among others.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusMaharashtra governmentCoronavirus Vaccine

First Published: Sep 02 2021 | 11:44 PM IST

Next Story